Healthcare Professionals
Please log in for special information and services
Lionella Sabovcikova Marketing & Sales Coordinator

“Being a part of AOP Orphan, a company whose priority is to help patients with rare diseases, is very motivating. It is gratifying to work  in the team of experienced colleagues for the benefit of patients”

Facts & Figures

AOP Orphan is fully dedicated to pharmaceutical and clinical development as well as commercialization of drugs for more than 20 years already.

Our motivation at AOP Orphan is to help patients who suffer from rare diseases. We achieve this cooperating with stakeholders of the Slovak health care system. Partnerships within pharmaceutical and health care industry are crucial for finding and providing solutions for patients, especially in the treatment of orphan diseases. 

Slovakia occupies a special position among many countries where AOP Orphan is represented. In this market, the company began its development in 2006. AOP Orphan Slovakia is a team of around five employees in the Marketing & Sales, and Medical for all three therapeutic divisions.

300,000
people
PATIENTS WITH RARE DISEASES IN slovakia
In Europe those diseases that occur in less than 5 per 10,000 residents are defined as rare diseases. In Slovakia 300,000 people have been diagnosed with a rare disease.
AVAILABLE TREATMENTS
In Slovakia AOP Orphan provides seven products. 
 
7
products
3
areas
THREE THERAPEUTIC AREAS
AOP Orphan Slovakia covers three area of treatments: HematoOncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders.

Vision & Mission

Milestones